Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 295/13 (2006.01) A61K 31/495 (2006.01) A61K 31/496 (2006.01) A61K 49/00 (2006.01) A61P 25/28 (2006.01) C07D 215/12 (2006.01) C07D 219/10 (2006.01) C07D 235/30 (2006.01) C07D 239/26 (2006.01) C07D 277/28 (2006.01)

Patent

CA 2585983

Use of 1,4-bis (3-aminoalkyl) piperazine derivatives as defined in formula I or II for the manufacture of a pharmaceutical composition intended for the treatment of neurodegenerative diseases, related neurodegenerative diseases, developmental diseases or cancer. The instant invention is also directed to some specific 1,4-bis (3-aminoalkyl) piperazine derivatives and pharmaceutical composition including them.

L'invention porte sur l'utilisation de dérivés de la 1,4-bis (3-aminoalkyl) pipérazine de formule (I) et (II) pour la fabrication de préparations pharmaceutiques devant servir au traitement de maladies neurodégénératives et de maladies associées, de troubles du développement et du cancer. L'invention porte également sur certains dérivés spécifiques de la 1,4-bis (3-aminoalkyl) pipérazine et sur des préparations pharmaceutiques les contenant.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1721952

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.